Serum levels of polyclonal IgG, IgA and IgM are usually decreased in patients with multiple myeloma (MM); however, little is known about the prognostic significance of polyclonal levels of IgE in ...

Hyperammonemic encephalopathy is a rarely reported complication of multiple myeloma (MM ... and perform a systematic review of the English-written literature. Our search yielded 26 more cases.

This method streamlines several analyses into a single test, reduces material requirements, and improves prognostic stratification for patients with multiple myeloma. The pan-genomic nature of ...

Therapies targeting a key G protein–coupled receptor may prove to be an important advancement in the treatment of multiple myeloma, a new review suggests. The study authors noted that therapies ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic ...

OGM provides a comprehensive genomic profile that can be used to support more precise prognostic risk stratification “Multiple myeloma is one of the most requested cancer types by customers ...

has dosed the 19th patient in its ongoing Phase 2 clinical trial evaluating GPC-100 (burixafor), a small molecule CXCR4 inhibitor, for the mobilization of stem cells in multiple myeloma (MM ...